Effect of exogenous thyrotropin-releasing hormone (TRH) administration on plasma levels of triiodothyronine (T3), thyroxine (T4) and growth hormone (GH) in chronically catheterized suckling piglets.

The purpose of the present study was to determine experimental conditions to stimulate secretion of thyroid hormones (T₃ and T₄) with thyrotropin-releasing hormone (TRH) injections in suckling piglets during the first weeks of postnatal life. Three consecutive experiments were conducted. Four 10–20 d old piglets were i.m. injected with 0, 20, 100, 500 μg (experiment 1) or 0, 4, 20, 100 μg TRH/kg BW (experiment 2) according to a 4 × 4 latin square design involving different litters in each experiment. Blood samples were taken −15, −1, 15, 30, 45, 60, 90, 120 180 and 300 min after TRH injection in experiment 1, and −.25, −.08, .25, .5, 1, 2, 4, 6, 8, 12, 24, 30, 36, 48, 60 and 72 hr after TRH injection in experiment 2. T₃ and T₄ levels were significantly (P<.01) increased as soon as 30 and 45 min after TRH injection, respectively. Maximal levels of T₃ and T₄ were obtained 2 and 4 hr after the injection of 100 μg TRH. T₃ and T₄ returned to basal levels within 6 and 8 hr post injection, respectively. Plasma pGH levels were significantly (P<.001) increased 15 min after TRH injection in piglets injected with 500 μg. In experiment 3, 100 μg TRH/kg BW were injected i.m. either daily or every other day from .0 to 23 days of age. Results showed that T₄ response to TRH did not decrease after repeated injections. These results indicate that daily i.m. injections of 100 μg TRH/kg BW can be used to increase thyroid hormone levels for at least 13 d in the young suckling piglet.     

Effect of bursal antisteroidogenic peptide (BASP) on chicken embryonic pituitary secretion of growth hormone (GH) and prolactin (PRL): evaluation in a reverse hemolytic plaque assay (RHPA)

Using the reverse hemolytic plaque assay described in the present investigation, a secretagogue activity of bursal antisteroidogenic peptide (BASP) for growth hormone (GH) or prolactin (PRL) secretion was observed in chicken Day 20e pituitary cell monolayers. Partially purified BASP (ppBASP), at all concentrations evaluated (0.25 BEQ/ml, 0.75 BEQ/ml, or 1.5 BEQ/ml), induced PRL secretion by isolated lactotrophs above (P < 0.05) basal levels during the 2- and 6-hr incubation. At the 18-hr time point, neither ppBASP nor vasoactive intestinal polypeptide (VIP) was efficacious (P < 0.05) in causing an elevation in PRL-secreting cells above basal levels. ppBASP, at all concentrations evaluated (0.25 BEQ/ml, 0.75 BEQ/ml, or 1.5 BEQ/ml), caused an increase in the percentage of GH-secreting cells above (P < 0.05) basal levels during the 18-hr incubation. When evaluating the 2-hr time point alone, ppBASP, at 0.75 or 1.5 BEQ/ml, significantly (P < 0.05) elevated the percentage of GH-secreting cells to above basal levels. After the 6-hr incubation, ppBASP at 0.25 or 0.75 BEQ/ml, was efficacious in causing elevated (P < 0.05) GH secretion above basal levels. The present study indicates a secretagogue activity of BASP on PRL or GH secretion by chicken embryonic anterior pituitary cells in vitro.     

Progestin-induced growth hormone (GH) production in the treatment of dogs with congenital GH deficiency

The recent demonstration of the ability of progestins to induce the expression of the growth hormone (GH) gene in the mammary gland of dogs and cats opens possibilities for the treatment of some forms of GH deficiency with progestins. Therefore, one male and one female German shepherd dog with congenital dwarfism because of a pituitary anomaly were treated with subcutaneous injections of medroxyprogesterone acetate (MPA) in doses of 2.5–5.0 mg per kg body weight, initially at 3-wk intervals and subsequently at 6-wk intervals. In both dogs, body sizes increased and a complete adult hair coat developed. Undesirable side-effects were recurrent periods of pruritic pyoderma in both dogs and cystic endometrial hyperplasia with mucometra in the female dog. Parallel with the physical improvements, plasma insulin-like growth factor I concentrations rose sharply. Plasma GH concentrations tended to rise, but never exceeded the upper limit of the reference range. Nevertheless, one of the dogs developed slight acromegalic features, possibly because mammary GH, unlike pituitary GH, is released evenly throughout the day. Even moderate increases in circulating GH concentration may, therefore, give rise to overexposure. It is concluded that long-term treatment with MPA can be used as an alternative for heterologous GH in the treatment of congenital GH deficiency in the dog.     

Effect of dose and route of administration of thyroid releasing hormone (TRH) on the concentration of prolactin (PRL) and thyroxine (T4) in cyclic gilts

Our objective was to examine the ability of thyroid releasing hormone (TRH) to stimulate not only the release of the thyroid hormones, but also prolactin (PRL) in the female pig. An experiment was conducted to determine the effect of dose and route of administration of TRH on the concentration of PRL and thyroxine (T4) in cyclic gilts. Six gilts were injected with 0, 5, 25, 125, and 625 micrograms TRH and fed 0, 5, 2.5, 12.5 and 62.5 mg TRH. Gilts received TRH once daily. During the 10-day treatment period, route of TRH administration alternated between i.v. injection and feeding. The dose of TRH progressed from the lowest to the highest. Blood samples were taken prior to TRH injection and thereafter at 15-min intervals for 3 hr. Sampling continued for an additional 3 hr at 30-min intervals when TRH was fed. Concentrations of PRL and T4 were determined by radioimmunoassay. Intravenous injection of gilts with 125 and 625 micrograms TRH resulted in an increase in PRL from 0 to 15 min (P less than .05). All doses of TRH given i.v. elevated T4 over a 2-hr period (P less than .01). TRH failed to increase PRL when TRH was fed (P greater than .5). The feeding of 62.5 mg TRH elevated T4 from 0 to 6 hr (P less than .01). Thus, TRH injection increased PRL rapidly and T4 gradually. When TRH was fed, only a gradual elevation in T4 was observed. We conclude that TRH can elicit the release of both PRL and T4 in the cyclic gilt, but magnitude and duration of the PRL and T4 response depends on the dose and route of TRH administration.     

Relationship of estrone and prolactin with growth and survival of piglets to 35 d of age

The relationship between estrogen or prolactin (Prl) status of pigs at birth and subsequent performance was examined in ten (Study 1) or seven (Study II) Yorkshire litters. In both studies, piglets were bled (3 ml) from the suborbital sinus at birth, and then hourly for 12 h. Hematocrit (Hct) and concentrations of plasma protein (PP) and estrone (E1) were determined on all samples. Concentrations of Prl were determined only in samples at birth. Weights at 3 and 5 wk of age as well as percent survival to 5 wk were obtained. Mean concentrations of E1 and Prl in piglets at birth were 6.97 +/- 44 ng/ml and 9.12 +/- .32 ng/ml, respectively. A decrease in E1 occurred over the first few hours after birth. Hematocrit values also decreased postnatally, whereas concentrations of PP increased. Sex of neonate did not affect any of the blood characteristics studied. Correlations between E1, PP, Hct and Prl at birth and body weights at birth, 3 and 5 wk were nonsignificant. However, piglets with higher Prl values at birth showed a greater survival rate. In Study II, half of the piglets in each litter were implanted at birth with silicone rubber implants containing estradiol-17 beta. Estrone concentrations were significantly higher in implanted piglets than in controls over the subsequent 12-h period, but Hct and PP values were not affected by treatment, suggesting that treated piglets did not consume more colostrum.(ABSTRACT TRUNCATED AT 250 WORDS)     

Inability of heterologous growth hormone (GH) to regulate GH binding protein in GH-transgenic swine

Transgenic pigs expressing bovine, ovine, or human growth hormone (GH) structural genes fused to mouse metallothionein-I (mMT-bGH), ovine MT (oMT-oGH), or mouse transferrin (mTf-hGH) promoters were used to study the effects of GH on the regulation of serum GH-binding protein (GHBP). In the 14 transgenic pigs studied, circulating concentrations of heterologous GH ranged from 15 to 2,750 ng/mL. Using chromatographic methods, specific binding of GH was detected in serum from normal pigs but was undetectable in serum from all the transgenic pigs used, probably as a result of the high serum concentrations of heterologous GH present in these animals. Thus, to avoid interference of binding by high GH concentrations, serum samples were subjected to immunoblotting using a specific anti-GHBP antibody. A specific 54-kDa band was detected in normal pig serum as well as in sera from mMT-bGH, oMT-oGH, and mTf-hGH pigs. Additionally, sera from transgenic mMT-bGH pigs and their sibling controls were subjected to immunoprecipitation with an anti-GHBP antibody followed by immunoblotting with the same antibody. With this technique, we detected two specific bands of 53 and 45 kDa that could represent different degrees of glycosylation of GHBP. As determined by densitometric analysis the amount of GHBP in transgenic pig sera was similar to that detected in sera of the respective control animals. The amount of circulating GHBP remained unchanged even in oMT-oGH and mTf-hGH pigs that were exposed from birth to circulating concentrations of GH as high as 2,750 ng/mL. Thus, we conclude that heterologous GH do not act as modulators ofthe serum GHBP in pigs.     

Effect of triglycerides on growth hormone (GH)-releasing factor-mediated GH secretion in newborn calves

The effect of triglycerides (Tg) on GRF-mediated GH secretion was examined in 2 groups of twelve ten-day old male calves. Twelve calves were intravenously infused with a lipid-heparin solution (5 mg Tg and 0.3 IU heparin/kg body wt/min for 90 min). The twelve control calves received in the same way, the same volume of saline. Thirty minutes after the start of infusion, GRF 1–29 (human amide, 0.16 μg/kg body wt) was intravenously injected in six animals of each group.

Mean plasma GH levels reached peak concentrations in the 2 groups 5 min after GRF injection. However the area under the GH response curve, when lipid-heparin was given, was significantly diminished compared to the response when saline was given. In the same time, lipid-heparin treatment increased plasma SRIF concentration. These data suggest that an increase in plasma Tg concentration, induced by lipid-heparin infusion, inhibits GRF-mediated GH secretion, possibly through stimulation of SRIF secretion.     

Effects of intracerebroventricular corticotropin-releasing hormone and intravenous morphine on cortisol, prolactin and growth hormone secretion in sheep.

It has previously been demonstrated that naloxone and morphine modify the adrenocortical and pituitary responses of sheep to stress. Since CRH acts within the brain to co-ordinate the stress response, the present experiment was conducted to determine whether morphine has similar effects in sheep given oCRH centrally. Plasma concentrations of cortisol, prolactin and growth hormone were measured in blood samples collected at 10 min intervals from sheep (N = 5) over a 3-hr period. Intravenous injections of saline vehicle or morphine sulphate (0.4 mg/kg) were given after 40 min and intracerebroventricular injections of oCRH (0, 5 or 20 micrograms) were administered after 60 min. Sustained, dose-related, increases in cortisol were induced by oCRH and, in agreement with findings in stressed sheep, these responses were reduced by pretreatment with morphine. Prolactin levels appeared to increase after morphine but oCRH, on its own, did not increase prolactin secretion in this study. There was no change in growth hormone concentrations after oCRH whereas morphine transiently stimulated release.     

Relationship between growth hormone (GH) pulses in the peripheral circulation and GH-releasing hormone and somatostatin profiles in the cerebrospinal fluid of goats

Growth hormone (GH) is secreted in a pulsatile manner, but the underlying mechanisms of GH pulse generation remain to be resolved. In the present study, we investigated the relationship between GH pulses in the peripheral circulation and GH-releasing hormone (GHRH) and somatostatin (SRIF) profiles in the cerebrospinal fluid (CSF) of male goats. The effects of an intracerebroventricular (icv) injection of neuropeptide Y (NPY), galanin and ghrelin were also analyzed. Blood and CSF samples were collected every 15 min for 8 hr from the jugular vein and third ventricle, respectively. GH pulsatility in the goat was found to consist of distinct large pulses of 5 hr periodicity and small pulses of 1 hr periodicity. GHRH and SRIF in the CSF fluctuated in a pulsatile manner with 1 hr periodicity, and most of the descending phase of SRIF pulses were associated with the initiation of GH pulses. Icv injections of NPY, galanin and ghrelin stimulated GHRH release without affecting SRIF release. In addition, NPY suppressed, and galanin and ghrelin induced large GH pulses, although ghrelin was much more effective than galanin. These results suggest that an hourly fall in SRIF is involved in generating intrinsic circhoral rhythm of GH pulsatility. The mechanisms underlying the generation of large GH pulses of 5 hr periodicity remain unknown, while direct action of NPY and/or ghrelin on the pituitary might be involved.     

Oral administration of peptidergic growth hormone (GH) secretagogue KP102 stimulates GH release in goats

To assess the oral activity of KP102 (also known GHRP-2) on growth hormone (GH) release in ruminant animals, 5 or 10 mg/kg body weight (BW) of KP102 dissolved in saline was orally administered twice at 2 hr-intervals to either 1- or 3-mo-old goats (n = 5-6). Plasma GH concentrations in the 1-mo-old goats were elevated at 15 min after the first administration of both 5 and 10 mg/kg BW of KP102. Significant elevation of GH concentrations continued until 180 min after 10 mg/kg BW of KP102, whereas the elevated GH levels after the administrations of 5 mg/kg BW of KP102 subsided to basal concentrations within 90 min. The second administration of 10 mg/kg BW of KP102 failed to elevate the GH concentration, but 5 mg/kg BW of KP102 abruptly stimulated GH release. Plasma GH concentrations in the 3-mo-old goats were also significantly elevated after the administration of both 5 and 10 mg/kg BW of KP102. The plasma GH responses to 5 and 10 mg/kg BW of KP102 were almost identical. The elevated GH levels after the first administration of KP102 tended to be maintained throughout the experiment, and a transient increase in plasma GH levels was observed after the second administration. However, the stimulatory effect of KP102 on GH release in the 3-mo-old goats was small and less abrupt than that in the 1-mo-old goats. The concentrations of insulin-like growth factor-I were not increased by KP102 during the brief sampling periods used in this experiment. These results show that the oral administration of the peptidergic GH secretogogue KP102 stimulates GH release in a ruminant species, and that the oral activity of KP102 on GH release is modified by the age.     

Relationship between age, nutritional status and dairy merit with plasma profiles of growth hormone (GH) and free fatty acids (FFA) in bulls

SUMMARY: Blood plasma levels of growth hormone (bGH) and of free fatty acids (FFA) were measured in repeated samples drawn every 15' for bHG, every 1 h for FFA one day after morning feeding and after 3 days of severe feed restriction of 7 young (< 2 years) and 14 old (> 5 years) bulls. The numerous data were condensated by the PULSAR program of Merriam and Wachter (1982) to mean level, average baseline concentration, number, average amplitude and average duration of secretory peaks. Young bulls had higher values for all of these parameters except peak duration and increased these after fast except for peak duration, baseline and integral while mature bulls reacted little to food restriction. FFA plasma levels were higher in young bulls under normal feeding when mature bulls had more frequent peaks. After feed restriction mature bulls increased the mean plasma level to the increased level of young bulls but decreased the peak frequency. The milk protein yield breeding values are related significantly to mean level, integral and the peak duration of plasma bGH levels but in different directions in young and in mature bulls. ZUSAMMENFASSUNG: Beziehungen zwischen Alter, Futterstatus, Milchzuchtwert und Plasmaspiegel von Wachstumshormon (GH) und Freien Fetts?uren (FFA) bei Stieren Blutplasmaspiegel von Wachstumshormon (GH) und Freien Fetts?uren (FFA) wurden in wiederholten Proben gemessen, die im Falle von GH alle 15 min. und im Falle von FFA jede Stunde einen Tag nach Morgenfütterung, nach drei Tagen starker Futterrestriktion bei sieben jungen (weniger als zwei Jahre) und 14 alten (über fünf Jahre) Stieren gezogen worden waren. Die zahlreichen Daten wurden mit Hilfe des Computerprogrammes von Merriam und Wachter (1982) kondensiert zu durchschnittlichen Plasmaspiegel, durchschnittliche Basiskonzentration, Zahl, durchschnittliche Amplitude und durchschnittliche Dauer von Sekretionsspitzen und Integral. Die Jungstiere hatten für alle diese Parameter h?here Werte, au?er der Dauer von Sekretionsspitzen und nahmen mit Ausnahme von dieser, von Basisspiegel und Integral nach Futterrestriktion zu, w?hrend Altstiere auf diese sehr wenig reagiert haben. FFA-Plasmaspiegel waren bei jungen Stieren h?her unter Normalfütterung, w?hrend alte Stiere h?ufiger Sekretionsspitzen zeigten. Nach Futterrestriktion steigerten Altstiere den mittleren Plasmaspiegel auf den angestiegenen Spiegel junger Stiere, aber verminderten die H?ufigkeit der Sekretionsspitzen. Milchprotein-Zuchtwerte sind signifikant mit mittlerem Plasmaspiegelwert, Integral und Dauer der Sekretionsspitzen bei Plasma GH korreliert, aber in verschiedener Richtung bei jungen und bei Altstieren.     

Immunohistochemical detection of growth hormone (GH) in canine hepatoid gland tumors

The aim of this study was to detect immunohistochemically means growth hormone (GH) in 24 hepatoid gland adenomas and 5 hepatoid gland carcinomas and to compare the difference of immunoreactivity between types of tumors. The tumors were classified according to the WHO standards. Tissue sections which were prepared from formalin-fixed, paraffin wax-embedded tissues from 25 male and 4 female dogs were carried out immunostaining using polyclonal primary anti-hGH and EnVision method. Of 24 hepatoid gland adenomas (perianal gland adenomas) 23 (95.8%) were positive. All 5 hepatoid gland carcinomas (perianal gland carcinomas) were positive. No statistically significant differences in percentage of labelled cells between malignant and benign tumors were seen. The present demonstration of GH in hepatoid gland tumors adds new data on GH in extra-pituitary tissues and hormon-dependent tumors.     

Compensatory growth of broiler chickens is associated with an enhanced pulsatile growth hormone (GH) secretion: Preferential amplification of GH secretory burst mass

1. The present study was conducted to establish the effect of compensatory growth of broiler chickens on pulsatile growth hormone (GH) secretion.

2. Exposing male broiler chickens to intermittent lighting (IL) at 10 d of age was associated with a transient reduction in body weight gain which was followed by compensatory growth from 4 weeks of age onwards. At 34 d of age, cannulated IL broiler chickens manifesting compensatory growth and control chickens reared under continuous illumination (CL) were serially sampled at 10 min intervals over 5 consecutive hours and plasma GH concentrations measured. The resultant GH time series were analysed by deconvolution analysis.

3. The overall mean GH concentration was higher for IL than for GL broilers. The burst frequency did not differ between lighting treatments, but during each GH surge, IL broilers released a higher GH mass which resulted in higher GH amplitude values. As a consequence, GH production rates of IL broilers during the entire sampling session were markedly elevated compared to those of dieir age‐matched CL broilers. There were no differences in the monoexponential GH half‐life.

4. Compensatory growth in broiler chickens is associated with an amplification of GH secretory burst mass. The underlying causal mechanisms remain to be elucidated.     

Effects of photoperiod on growth, carcass composition, prolactin, growth hormone and cortisol in prepubertal and postpubertal Holstein heifers

Effects of photoperiod on growth, carcass composition and serum concentrations of prolactin, growth hormone and cortisol were determined in prepubertal and postpubertal Holstein heifers. Forty-two prepubertal (avg body wt 84 +/- 3.0 kg) and 42 postpubertal (avg body wt 303 +/- 7.1 kg) Holstein heifers were utilized. Ten prepubertal and 10 postpubertal heifers were slaughtered before treatment began to obtain initial carcass data. The remaining 32 prepubertal and 32 postpubertal heifers were paired by body weight and randomly assigned to short-day (8 h of light: 16 h of dark) or long-day (16 h of light: 8 h of dark) photoperiods. After exposure to treatments for an average of 139 d, 10 prepubertal and 10 postpubertal heifers from each photoperiod treatment were slaughtered. In prepubertal heifers, photoperiod did not affect (P greater than .10) average daily body weight gain, carcass weight, carcass composition, accretion of carcass fat and carcass protein, or serum concentrations of prolactin, growth hormone or cortisol. However, prepubertal heifers exposed to long-day photoperiods had reduced (P less than .01) urinary N tau-methylhistidine excretion compared with heifers given short-day photoperiods. Postpubertal heifers exposed to short-day photoperiods had greater average body weight daily gain than animals exposed to long-day photoperiods. Although there was no effect of photoperiod (P greater than .10) on carcass or fat depot weights, postpubertal heifers exposed to short days had greater (P = .06) percentages of fat and reduced (P = .07) percentages of protein in the soft tissue of the 9-10-11 rib sections. Fat accretion was greater (P less than .05) in carcasses of postpubertal heifers exposed to short days than heifers given long-day photoperiods, but there was no effect (P greater than .10) of photoperiod on protein accretion. Photoperiod did not affect serum concentrations of growth hormone and cortisol, but serum prolactin tended (P less than .10) to be greater in postpubertal heifers exposed to long days. Under the conditions of this experiment, we conclude that exposure to short-day photoperiods stimulated body weight gain and fat accretion in postpubertal but not prepubertal Holstein heifers.     

Growth and carcass characteristics and serum growth hormone, prolactin and insulin profiles in Debouillet lambs treated with ovine growth hormone and(or) zeranol

Sixteen Debouillet wether lambs (approximately 3 mo old) were placed indoors in 1.5- x 3-m pens (14 h light:10 h dark) 28 d after weaning. Lambs received no implant or a 12-mg zeranol implant on d-2 (eight lambs/group). Two days later (d 0), animals received either 0 or 2.5 mg ovine growth hormone (oGH, eight lambs/group) s.c. on alternate days for 42 d. Animals had ad libitum access to water, salt, mineral and a pelleted alfalfa diet (16% CP). After 42 d, lambs were slaughtered to evaluate carcass traits, organ weights and femur characteristics. Zeranol by oGH interactions were not detected (P greater than .20). Zeranol increased (P less than .05) BW, improved (P less than .05) feed:gain during the first 20 d and increased (P less than .10) feed intake during the last 22 d of the 42-d trial compared with controls. Carcass characteristics were not altered (P greater than .10) by 12 mg zeranol. Serum insulin and prolactin were elevated (P less than .05), but serum GH was not influenced by zeranol compared with controls. Exogenous oGH decreased feed intake (P less than .10) and improved feed:gain (P less than .05) during the initial 20 d compared with controls, but did not influence (P greater than .20) these variables during the last 22 d of the study. Carcass traits were not influenced (P greater than .10) by oGH. Exogenous ovine GH dramatically elevated (P less than .05) serum GH, but did not affect serum insulin or prolactin (P greater than .10).(ABSTRACT TRUNCATED AT 250 WORDS)     

New insights into the mechanism and actions of growth hormone (GH) in poultry.

Despite well documented anabolic effects of GH in mammals, a clear demonstration of such responses in domestic poultry is lacking. Recently, comprehensive dose-response studies of GH have been conducted in broilers during late post-hatch development (8 to 9 weeks of age). GH reduced feed intake (FI) and body weight gain in a dose-dependent manner, whereas birds pair-fed to the level of voluntary FI of GH-infused birds did not differ from controls. The reduction in voluntary FI may involve centrally mediated mechanisms, as hypothalamic neuropeptide Y protein and mRNA were reduced with GH, coincident with the maximal depression in FI. Growth of breast muscle was also reduced in a dose-dependent manner. Circulating IGF-I was not enhanced by GH, despite evidence that early events in the GH signaling pathway were intact. A GH dose-dependent increase in circulating 3,3',5-triiodothyronine(T3) paralleled decreases in hepatic 5D-III monodeiodinase activity, whereas 5'D-I activity was not altered. This confirms that a marked hyperthyroid response to GH occurs in late posthatch chickens, resulting from a decrease in the degradative pathway of T3 metabolism. This secondary hyperthyroidism would account for the decreased skeletal muscle mass (52) and lack of enhanced IGF-I (53) in GH-treated birds. Based upon these studies, it is now evident that GH does in fact have significant effects in poultry, but metabolic responses may confound the anabolic potential of the hormone.